When the theme of our inaugural event was “Disrupt or Be Disrupted” little did we know that a pandemic was on the horizon. This panel is going to take an indepth look at just how COVID changed Telehealth, accelerated its implementation and what the landscape looks like now. A discussion will begin by defining telehealth broadly and sharing the latest statistics on adoption and usage. We’ll review a few barriers to growth and explore how the FDA approval process has evolved under COVID. By its very nature, telehealth is also disrupting specific areas of care; we’ll look at who is being disrupted and how mobile apps are defining new standards of care for both episodic and chronic health conditions. Finally, we’ll discuss data collection and how it can engender more proactive approaches to treatment.